NASDAQ NMS - GLOBAL MARKET · COCH
-2.45% · -$0.0161 · Vol 57.3K
Envoy Medical Inc

Envoy Medical Inc

Health Care
$0.6418

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is COCH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Envoy Medical Inc
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Founded
Listed
2023
Employees
47
HQ
US

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$0.6430
Day high
$0.6783
Day low
$0.6210
Previous close
$0.6579
52W high
$0.6500
-1.26% from high
52W low
$0.6418
0% of range
Market cap
$48.3M
P/E
EPS
Dividend yield
Beta
Shares out
76.9M
Float
Volume
57.3K
Avg volume
VWAP
$0.6425
Next earnings
Price history computed in-house
1W
-1.26%
1M
-1.26%
3M
-1.26%
1Y
-1.26%
YTD
-1.26%
SMA 50 $0.6459 · below
SMA 200 $0.6459 · below
52W position 0%
Veridion warehouse edge

Warehouse intelligence for COCH.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

COCH insider activity

Envoy Medical Inc

Score
Coverage building
Pressure
Net buying
Filings
8
Buys / sells
8 / 0
Net value
$8.2M
Insiders
6
Named filers
LT
Lucas Brent T.
Insider
Leadership
PC
Patel Mona Chetan
Insider
Leadership
PR
Potashnick Robert
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $8.2M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-042026-05-29Lucas Brent T.Insiderbuy$0.6032,856329,946$20KSEC Form 4
2026-02-172026-02-12Patel Mona ChetanInsiderbuy$0.40312,500332,500$125KSEC Form 4
2026-02-172026-02-12Potashnick RobertInsiderbuy$0.40212,500212,500$85KSEC Form 4
2026-02-172026-02-12Lucas Brent T.Insiderbuy$0.4062,500297,090$25KSEC Form 4
2026-02-172026-02-12BRYNELSEN CHARLESInsiderbuy$0.401,000,0001,050,000$400KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 3 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

COCH contract awards, year to date.

Public federal awards linked to this ticker.

Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for COCH in this window.
Lobbying spend

COCH lobbying filings, year to date.

Registered lobbying filings matched to Envoy Medical Inc.

$10.0K
Refresh interval: 12hSource: LDA disclosure filings
Medicare/Medicaid
Filing
$10.0K
ENVOY MEDICAL CORPORATION

SIDLEY AUSTIN LLP

Jan 20, 2026
Latest news · COCH
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for COCH.
Options
Sovereign unlock shows live options positioning for COCH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.